CAS No. |
2098181-84-9 |
|---|---|
中文名称 |
2-((6S,9S,12S,15S,18S,21S,23aS,29R,34R,37S,39aS)-29-((9S,12S,15S,18S)-9-氨基-12,15,18-三(3-胍基丙基)-4-亚胺基-2,10,13,16-四氧代-3,5,11,14,17-五氮杂十九烷-19-酰胺基)-15-((S)-仲丁基)-34-(((6S,9S,12S,15S)-1,20-二氨基-6-氨甲酰基-9,12-二(3-胍基丙基)-1,20-二亚胺基-8,11,14-三氧代-2,7,10,13,19-五氮杂二十烷-15-基)氨甲酰基)-9,18-二(4-羟基苄基)-12-(羟甲基)-21-异丁基-37-异丙基-5,8,11,14,17,20,23,28,36,39-十氧代-四十三烷氢化-1H,5H,28H-二吡咯并[2,1-e1:2',1'-j][1,2]二噻[5,8,11,14,17,20,23,26,29,32]十氮杂环五十三烯-6-基)乙酸 |
英文名称 |
2-((6S,9S,12S,15S,18S,21S,23aS,29R,34R,37S,39aS)-29-((9S,12S,15S,18S)-9-amino-12,15,18-tris(3-guanidinopropyl)-4-imino-2,10,13,16-tetraoxo-3,5,11,14,17-pentaazanonadecan-19-amido)-15-((S)-sec-butyl)-34-(((6S,9S,12S,15S)-1,20-diamino-6-carbamoyl-9,12-bis(3-guanidinopropyl)-1,20-diimino-8,11,14-trioxo-2,7,10,13,19-pentaazaicosan-15-yl)carbamoyl)-9,18-bis(4-hydroxybenzyl)-12-(hydroxymethyl)-21-isobutyl-37-isopropyl-5,8,11,14,17,20,23,28,36,39-decaoxotetratriacontahydro-1H,5H,28H-dipyrrolo[2,1-e1:2',1'-j][1,2]dithia[5,8,11,14,17,20,23,26,29,32]decaazacyclopentatriacontin-6-yl)acetic acid |
标准英文名 |
2-((6S,9S,12S,15S,18S,21S,23aS,29R,34R,37S,39aS)-29-((9S,12S,15S,18S)-9-amino-12,15,18-tris(3-guanidinopropyl)-4-imino-2,10,13,16-tetraoxo-3,5,11,14,17-pentaazanonadecan-19-amido)-15-((S)-sec-butyl)-34-(((6S,9S,12S,15S)-1,20-diamino-6-carbamoyl-9,12-bis(3-guanidinopropyl)-1,20-diimino-8,11,14-trioxo-2,7,10,13,19-pentaazaicosan-15-yl)carbamoyl)-9,18-bis(4-hydroxybenzyl)-12-(hydroxymethyl)-21-isobutyl-37-isopropyl-5,8,11,14,17,20,23,28,36,39-decaoxotetratriacontahydro-1H,5H,28H-dipyrrolo[2,1-e1:2',1'-j][1,2]dithia[5,8,11,14,17,20,23,26,29,32]decaazacyclopentatriacontin-6-yl)acetic acid |
分子式 |
C108H182N44O25S2 |
分子量 |
2561.06 |
精确分子量 |
2559.38 |
SMILES |
CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)NC(C)=O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC1=O |
标准SMILES |
CC(=O)NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2C=CC(O)=CC=2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2C=CC(O)=CC=2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C1=O)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O |
用途 |
KRPEP-2D is used in cancer research as a potent K-Ras inhibitor that suppresses K-Ras-driven cancer cell proliferation. |
InChIKey |
PNSDZPKWIOBSHR-WVEXBLHFSA-N |
|
|
评论 |
|---|